Automated External Defibrillator Market, By Product Outlook (Manual External Defibrillators, Automated External Defibrillators [Semi-Automated ED, Fully Automated ED], Wearable Cardioverter Defibrillators), By End-use Outlook (Hospital, Pre-Hospital, Public Access Market, Alternate Care Market, Home Healthcare), By Region - Global Analysis Forecast Till 2030

The Global Automated External Defibrillator Market was valued at USD 3 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 9.9% between 2022 and 2030.

Automated external defibrillators (AEDs) are life-saving devices that regulate the heartbeat. AEDs are portable medical devices used to treat sudden cardiac arrest, a condition in which the heart suddenly stops beating. Cardiopulmonary resuscitation and early defibrillation effectively save lives when administered within the first few minutes of a cardiac arrest. Typically, this occurs when severance is caused by electrical activity in the heart, resulting in a dangerously fast or irregular heartbeat. Either of these irregular heart rhythms impairs the heart's ability to pump blood effectively and can lead to cardiac arrest.

Batteries and electrode pads are required for the AED to detect, interpret, and administer an electrical shock. The increasing prevalence of cardiac diseases, the growing geriatric population, technological advancements in the field, and increased investment by market participants are the primary contributors to the growth of the automated external defibrillator market. Furthermore, the prevalence of sedentary lifestyles and the global geriatric population contributes to an increase in the incidence of cardiovascular diseases.

Market Dynamics

Drivers:

Increasing rates of lifestyle disorders

The automated external defibrillator popularity is due to its ability to use an electric shock to the heart to help restore irregularities in heart rhythm. These devices are intended for the detection and treatment of two types of abnormal heart rhythms: ventricular fibrillation (VF) and pulseless ventricular tachycardia (PVT) (pulseless VT).

The increased use of this device in treating patients suffering from sudden cardiac arrest is expected to create revenue-generating opportunities in the global automated external defibrillator market in the coming years. Furthermore, increasing the number of people addicted to alcohol and smoking may open up lucrative market opportunities.

Restraints:

AED accessibility issues

AEDs installed in public places are occasionally prone to failure due to problems with the battery, software, and tackle.  Failure to perform defibrillation can result in delayed treatment or even death. Over the years, several defibrillators have been recalled due to technical errors in the device's functioning with respect to shock delivery, electrical issues, and hardware configuration.

These flaws can sometimes result in poor product performance and even patient death. In collaboration with Philips, the FDA issued a recall notice for several models of the HeartStart MRx Defibrillator in 2018. The recall was caused by a defect in the gas discharge tube (GDT), which could cause the defibrillator to malfunction. These factors may hamper the growth of the automated external defibrillator market.

Key players:

• Koninklijke Philips N.V.

• Stryker

• Zoll Medical Corporation, an Asahi Kasei Group Company

• Nihon Kohden Corporation

• ProgettiSrl

• Schiller AG

• MS Westfalia GmbH

• AMI Italia

• Bexen Cardio

• Silverline Meditech Pvt. Ltd.

• Mediana Co., Ltd.

• Shenzhen Mindray Bio-Medical Electronics

• CU Medical

• BPL Medical Technologies

• Corpuls

• Dixion Vetrieb medizinischer Geräte GmbH

• Bioevopeak Co., Ltd.

Market Segmentation:

Automated External Defibrillator

Automated External Defibrillator Market, By Product Outlook

• • Manual External Defibrillators

  • Automated External Defibrillators

    • Semi-Automated ED

    • Fully Automated ED

  • Wearable Cardioverter Defibrillators

Automated External Defibrillator Market, By End-use Outlook

• • Hospital

  • Pre Hospital

  • Public Access Market

  • Alternate Care Market

  • Home Healthcare

Automated External Defibrillator Market, By Regional Outlook

• • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Netherlands

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

Regional Analysis:

In 2021, North America had a profit share of further than 43. The large share of the North American region can be attributed to the presence of crucial players, probative regulations to increase the vacuity of public access AEDs, and the high relinquishment of external defibrillators at healthcare installations. Numerous public organizations in the United States, including the American Heart Association (AHA), advocate for comprehensive Public Access Defibrillation (PAD) programs. The attributes suggested for such a program include targeted placement of AEDs (including routine conservation and testing), responder training, EMS collaboration, and ongoing quality enhancement. 

Over the coming many times, Europe is anticipated to have the fastest CAGR in the external defibrillator request. This is owing to a well-established healthcare structure, a large senior population susceptible to cardiovascular adverse events, and the original presence of crucial companies.

Scope of the Report:

User

Tab Content